-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Treatment Option for Patients with Myelodysplastic Syndromes

Program: Product Theaters
Session: A Treatment Option for Patients with Myelodysplastic Syndromes
Sunday, December 6, 2020, 11:00 AM-12:00 PM

Jeffrey A. Jones, MD, MPH

Bristol Myers Squibb, Summit, NJ

Disclosures: No relevant conflicts of interest to declare.

See more of: A Treatment Option for Patients with Myelodysplastic Syndromes
See more of: Product Theaters